Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773)

Market Cap	17.90B
Revenue (ttm)	4.37B
Net Income (ttm)	1.19B
Shares Out	919.78M
EPS (ttm)	1.30
PE Ratio	14.97
Forward PE	14.31
Dividend	0.38 (1.94%)
Ex-Dividend Date	May 28, 2024

Volume	8,607,179
Open	20.08
Previous Close	19.57
Day's Range	19.43 - 20.08
52-Week Range	13.15 - 24.50
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Chengdu Kanghong Pharmaceutical Group

Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. It also develops ophthalmic medical devices. The company offers central nervous, digestive, and endocrine system drugs. Chengdu Kanghong Pharmaceuticals Group Co., Ltd. was founded in 1996 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,289
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002773

Financial Performance

In 2023, Chengdu Kanghong Pharmaceutical Group's revenue was 3.96 billion, an increase of 16.77% compared to the previous year's 3.39 billion. Earnings were 1.04 billion, an increase of 16.52%.